Cargando…
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
BACKGROUND: Cysteinyl leukotrienes (CysLTs) are potent pro-inflammatory mediators that are increased in samples from patients with inflammatory bowel diseases (IBDs). Individuals with IBDs have enhanced susceptibility to colon carcinogenesis. In colorectal cancer, the balance between the pro-mitogen...
Autores principales: | Bengtsson, Astrid M, Jönsson, Gunilla, Magnusson, Cecilia, Salim, Tavga, Axelsson, Cecilia, Sjölander, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710469/ https://www.ncbi.nlm.nih.gov/pubmed/23829413 http://dx.doi.org/10.1186/1471-2407-13-336 |
Ejemplares similares
-
Regulation of Cysteinyl Leukotriene Receptor 2 Expression—A Potential Anti-Tumor Mechanism
por: Magnusson, Cecilia, et al.
Publicado: (2011) -
Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer
por: Osman, Janina, et al.
Publicado: (2017) -
Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021) -
Brain-Derived Neurotrophic Factor, Neutrophils and Cysteinyl Leukotriene Receptor 1 as Potential Prognostic Biomarkers for Patients with Colon Cancer
por: Mehrabi, Syrina F., et al.
Publicado: (2021) -
DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients
por: Ghatak, Souvik, et al.
Publicado: (2023)